img

Global H2 Antagonists or H2 blockers Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global H2 Antagonists or H2 blockers Market Insights, Forecast to 2034

H2 blockers are a group of medicines that reduce the amount of acid produced by the cells in the lining of the stomach. They are also called 'histamine H2-receptor antagonists' but are commonly called H2 blockers.
Market Analysis and InsightsGlobal H2 Antagonists or H2 blockers Market
Global H2 Antagonists or H2 blockers market is expected to reach to US$ 4120 million in 2024, with a positive growth of %, compared with US$ 4215 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, H2 Antagonists or H2 blockers industry is evaluated to reach US$ 3561.2 million in 2029. The CAGR will be -2.4% during 2024 to 2029.
The Histamine H2-receptor Antagonists market is primarily driven by the need for effective treatments for conditions related to excessive stomach acid production. Histamine H2-receptor antagonists, commonly known as H2 blockers, are medications used to reduce gastric acid secretion and alleviate symptoms of conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers. The increasing prevalence of acid-related disorders, coupled with the rising awareness of their impact on digestive health, contributes to market growth. Moreover, advancements in gastrointestinal medicine and the demonstrated efficacy of H2 blockers in providing symptom relief further propel adoption. However, challenges include optimizing dosing regimens and addressing potential interactions or side effects. Navigating patient-specific treatment needs, ensuring appropriate usage in conjunction with other medications, and managing long-term treatment plans are ongoing concerns. The market's success relies on continuous research into acid-related disorders, collaborations between pharmaceutical manufacturers and healthcare providers, and comprehensive patient education on the benefits and potential risks of H2-receptor antagonist treatments while addressing the evolving challenges associated with digestive health management and treatment accessibility.
Report Covers
This report presents an overview of global H2 Antagonists or H2 blockers market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global H2 Antagonists or H2 blockers market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Takeda
Pfizer
AstraZeneca
Bayer
Sun Pharma
Teva
Eisai Co.
Viatris
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Eastchina Pharma
Segment by Type
Oral
Injection

Segment by Application


Hospital
Drugs Store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, H2 Antagonists or H2 blockers introduction, etc. H2 Antagonists or H2 blockers Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of H2 Antagonists or H2 blockers
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global H2 Antagonists or H2 blockers Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global H2 Antagonists or H2 blockers Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global H2 Antagonists or H2 blockers Market Perspective (2018-2029)
2.2 Global H2 Antagonists or H2 blockers Growth Trends by Region
2.2.1 H2 Antagonists or H2 blockers Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 H2 Antagonists or H2 blockers Historic Market Size by Region (2018-2024)
2.2.3 H2 Antagonists or H2 blockers Forecasted Market Size by Region (2024-2029)
2.3 H2 Antagonists or H2 blockers Market Dynamics
2.3.1 H2 Antagonists or H2 blockers Industry Trends
2.3.2 H2 Antagonists or H2 blockers Market Drivers
2.3.3 H2 Antagonists or H2 blockers Market Challenges
2.3.4 H2 Antagonists or H2 blockers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue H2 Antagonists or H2 blockers by Players
3.1.1 Global H2 Antagonists or H2 blockers Revenue by Players (2018-2024)
3.1.2 Global H2 Antagonists or H2 blockers Revenue Market Share by Players (2018-2024)
3.2 Global H2 Antagonists or H2 blockers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of H2 Antagonists or H2 blockers, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global H2 Antagonists or H2 blockers Market Concentration Ratio
3.4.1 Global H2 Antagonists or H2 blockers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by H2 Antagonists or H2 blockers Revenue in 2022
3.5 Global Key Players of H2 Antagonists or H2 blockers Head office and Area Served
3.6 Global Key Players of H2 Antagonists or H2 blockers, Product and Application
3.7 Global Key Players of H2 Antagonists or H2 blockers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 H2 Antagonists or H2 blockers Breakdown Data by Type
4.1 Global H2 Antagonists or H2 blockers Historic Market Size by Type (2018-2024)
4.2 Global H2 Antagonists or H2 blockers Forecasted Market Size by Type (2024-2029)
5 H2 Antagonists or H2 blockers Breakdown Data by Application
5.1 Global H2 Antagonists or H2 blockers Historic Market Size by Application (2018-2024)
5.2 Global H2 Antagonists or H2 blockers Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America H2 Antagonists or H2 blockers Market Size (2018-2029)
6.2 North America H2 Antagonists or H2 blockers Market Size by Type
6.2.1 North America H2 Antagonists or H2 blockers Market Size by Type (2018-2024)
6.2.2 North America H2 Antagonists or H2 blockers Market Size by Type (2024-2029)
6.2.3 North America H2 Antagonists or H2 blockers Market Share by Type (2018-2029)
6.3 North America H2 Antagonists or H2 blockers Market Size by Application
6.3.1 North America H2 Antagonists or H2 blockers Market Size by Application (2018-2024)
6.3.2 North America H2 Antagonists or H2 blockers Market Size by Application (2024-2029)
6.3.3 North America H2 Antagonists or H2 blockers Market Share by Application (2018-2029)
6.4 North America H2 Antagonists or H2 blockers Market Size by Country
6.4.1 North America H2 Antagonists or H2 blockers Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America H2 Antagonists or H2 blockers Market Size by Country (2018-2024)
6.4.3 North America H2 Antagonists or H2 blockers Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe H2 Antagonists or H2 blockers Market Size (2018-2029)
7.2 Europe H2 Antagonists or H2 blockers Market Size by Type
7.2.1 Europe H2 Antagonists or H2 blockers Market Size by Type (2018-2024)
7.2.2 Europe H2 Antagonists or H2 blockers Market Size by Type (2024-2029)
7.2.3 Europe H2 Antagonists or H2 blockers Market Share by Type (2018-2029)
7.3 Europe H2 Antagonists or H2 blockers Market Size by Application
7.3.1 Europe H2 Antagonists or H2 blockers Market Size by Application (2018-2024)
7.3.2 Europe H2 Antagonists or H2 blockers Market Size by Application (2024-2029)
7.3.3 Europe H2 Antagonists or H2 blockers Market Share by Application (2018-2029)
7.4 Europe H2 Antagonists or H2 blockers Market Size by Country
7.4.1 Europe H2 Antagonists or H2 blockers Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe H2 Antagonists or H2 blockers Market Size by Country (2018-2024)
7.4.3 Europe H2 Antagonists or H2 blockers Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China H2 Antagonists or H2 blockers Market Size (2018-2029)
8.2 China H2 Antagonists or H2 blockers Market Size by Type
8.2.1 China H2 Antagonists or H2 blockers Market Size by Type (2018-2024)
8.2.2 China H2 Antagonists or H2 blockers Market Size by Type (2024-2029)
8.2.3 China H2 Antagonists or H2 blockers Market Share by Type (2018-2029)
8.3 China H2 Antagonists or H2 blockers Market Size by Application
8.3.1 China H2 Antagonists or H2 blockers Market Size by Application (2018-2024)
8.3.2 China H2 Antagonists or H2 blockers Market Size by Application (2024-2029)
8.3.3 China H2 Antagonists or H2 blockers Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia H2 Antagonists or H2 blockers Market Size (2018-2029)
9.2 Asia H2 Antagonists or H2 blockers Market Size by Type
9.2.1 Asia H2 Antagonists or H2 blockers Market Size by Type (2018-2024)
9.2.2 Asia H2 Antagonists or H2 blockers Market Size by Type (2024-2029)
9.2.3 Asia H2 Antagonists or H2 blockers Market Share by Type (2018-2029)
9.3 Asia H2 Antagonists or H2 blockers Market Size by Application
9.3.1 Asia H2 Antagonists or H2 blockers Market Size by Application (2018-2024)
9.3.2 Asia H2 Antagonists or H2 blockers Market Size by Application (2024-2029)
9.3.3 Asia H2 Antagonists or H2 blockers Market Share by Application (2018-2029)
9.4 Asia H2 Antagonists or H2 blockers Market Size by Region
9.4.1 Asia H2 Antagonists or H2 blockers Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia H2 Antagonists or H2 blockers Market Size by Region (2018-2024)
9.4.3 Asia H2 Antagonists or H2 blockers Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Type
10.2.1 Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Application
10.3.1 Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Country
10.4.1 Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda H2 Antagonists or H2 blockers Introduction
11.1.4 Takeda Revenue in H2 Antagonists or H2 blockers Business (2018-2024)
11.1.5 Takeda Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer H2 Antagonists or H2 blockers Introduction
11.2.4 Pfizer Revenue in H2 Antagonists or H2 blockers Business (2018-2024)
11.2.5 Pfizer Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca H2 Antagonists or H2 blockers Introduction
11.3.4 AstraZeneca Revenue in H2 Antagonists or H2 blockers Business (2018-2024)
11.3.5 AstraZeneca Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer H2 Antagonists or H2 blockers Introduction
11.4.4 Bayer Revenue in H2 Antagonists or H2 blockers Business (2018-2024)
11.4.5 Bayer Recent Developments
11.5 Sun Pharma
11.5.1 Sun Pharma Company Details
11.5.2 Sun Pharma Business Overview
11.5.3 Sun Pharma H2 Antagonists or H2 blockers Introduction
11.5.4 Sun Pharma Revenue in H2 Antagonists or H2 blockers Business (2018-2024)
11.5.5 Sun Pharma Recent Developments
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva H2 Antagonists or H2 blockers Introduction
11.6.4 Teva Revenue in H2 Antagonists or H2 blockers Business (2018-2024)
11.6.5 Teva Recent Developments
11.7 Eisai Co.
11.7.1 Eisai Co. Company Details
11.7.2 Eisai Co. Business Overview
11.7.3 Eisai Co. H2 Antagonists or H2 blockers Introduction
11.7.4 Eisai Co. Revenue in H2 Antagonists or H2 blockers Business (2018-2024)
11.7.5 Eisai Co. Recent Developments
11.8 Viatris
11.8.1 Viatris Company Details
11.8.2 Viatris Business Overview
11.8.3 Viatris H2 Antagonists or H2 blockers Introduction
11.8.4 Viatris Revenue in H2 Antagonists or H2 blockers Business (2018-2024)
11.8.5 Viatris Recent Developments
11.9 AOSAIKANG Pharma
11.9.1 AOSAIKANG Pharma Company Details
11.9.2 AOSAIKANG Pharma Business Overview
11.9.3 AOSAIKANG Pharma H2 Antagonists or H2 blockers Introduction
11.9.4 AOSAIKANG Pharma Revenue in H2 Antagonists or H2 blockers Business (2018-2024)
11.9.5 AOSAIKANG Pharma Recent Developments
11.10 Luoxin Pharma
11.10.1 Luoxin Pharma Company Details
11.10.2 Luoxin Pharma Business Overview
11.10.3 Luoxin Pharma H2 Antagonists or H2 blockers Introduction
11.10.4 Luoxin Pharma Revenue in H2 Antagonists or H2 blockers Business (2018-2024)
11.10.5 Luoxin Pharma Recent Developments
11.11 LIVZON
11.11.1 LIVZON Company Details
11.11.2 LIVZON Business Overview
11.11.3 LIVZON H2 Antagonists or H2 blockers Introduction
11.11.4 LIVZON Revenue in H2 Antagonists or H2 blockers Business (2018-2024)
11.11.5 LIVZON Recent Developments
11.12 Eastchina Pharma
11.12.1 Eastchina Pharma Company Details
11.12.2 Eastchina Pharma Business Overview
11.12.3 Eastchina Pharma H2 Antagonists or H2 blockers Introduction
11.12.4 Eastchina Pharma Revenue in H2 Antagonists or H2 blockers Business (2018-2024)
11.12.5 Eastchina Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global H2 Antagonists or H2 blockers Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global H2 Antagonists or H2 blockers Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global H2 Antagonists or H2 blockers Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global H2 Antagonists or H2 blockers Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global H2 Antagonists or H2 blockers Market Share by Region (2018-2024)
Table 8. Global H2 Antagonists or H2 blockers Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global H2 Antagonists or H2 blockers Market Share by Region (2024-2029)
Table 10. H2 Antagonists or H2 blockers Market Trends
Table 11. H2 Antagonists or H2 blockers Market Drivers
Table 12. H2 Antagonists or H2 blockers Market Challenges
Table 13. H2 Antagonists or H2 blockers Market Restraints
Table 14. Global H2 Antagonists or H2 blockers Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global H2 Antagonists or H2 blockers Revenue Share by Players (2018-2024)
Table 16. Global Top H2 Antagonists or H2 blockers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in H2 Antagonists or H2 blockers as of 2022)
Table 17. Global H2 Antagonists or H2 blockers Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by H2 Antagonists or H2 blockers Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of H2 Antagonists or H2 blockers, Headquarters and Area Served
Table 20. Global Key Players of H2 Antagonists or H2 blockers, Product and Application
Table 21. Global Key Players of H2 Antagonists or H2 blockers, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global H2 Antagonists or H2 blockers Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global H2 Antagonists or H2 blockers Revenue Market Share by Type (2018-2024)
Table 25. Global H2 Antagonists or H2 blockers Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global H2 Antagonists or H2 blockers Revenue Market Share by Type (2024-2029)
Table 27. Global H2 Antagonists or H2 blockers Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global H2 Antagonists or H2 blockers Revenue Share by Application (2018-2024)
Table 29. Global H2 Antagonists or H2 blockers Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global H2 Antagonists or H2 blockers Revenue Share by Application (2024-2029)
Table 31. North America H2 Antagonists or H2 blockers Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America H2 Antagonists or H2 blockers Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America H2 Antagonists or H2 blockers Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America H2 Antagonists or H2 blockers Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America H2 Antagonists or H2 blockers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America H2 Antagonists or H2 blockers Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America H2 Antagonists or H2 blockers Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe H2 Antagonists or H2 blockers Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe H2 Antagonists or H2 blockers Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe H2 Antagonists or H2 blockers Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe H2 Antagonists or H2 blockers Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe H2 Antagonists or H2 blockers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe H2 Antagonists or H2 blockers Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe H2 Antagonists or H2 blockers Market Size by Country (2024-2029) & (US$ Million)
Table 45. China H2 Antagonists or H2 blockers Market Size by Type (2018-2024) & (US$ Million)
Table 46. China H2 Antagonists or H2 blockers Market Size by Type (2024-2029) & (US$ Million)
Table 47. China H2 Antagonists or H2 blockers Market Size by Application (2018-2024) & (US$ Million)
Table 48. China H2 Antagonists or H2 blockers Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia H2 Antagonists or H2 blockers Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia H2 Antagonists or H2 blockers Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia H2 Antagonists or H2 blockers Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia H2 Antagonists or H2 blockers Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia H2 Antagonists or H2 blockers Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia H2 Antagonists or H2 blockers Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia H2 Antagonists or H2 blockers Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size by Country (2024-2029) & (US$ Million)
Table 63. Takeda Company Details
Table 64. Takeda Business Overview
Table 65. Takeda H2 Antagonists or H2 blockers Product
Table 66. Takeda Revenue in H2 Antagonists or H2 blockers Business (2018-2024) & (US$ Million)
Table 67. Takeda Recent Developments
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer H2 Antagonists or H2 blockers Product
Table 71. Pfizer Revenue in H2 Antagonists or H2 blockers Business (2018-2024) & (US$ Million)
Table 72. Pfizer Recent Developments
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca H2 Antagonists or H2 blockers Product
Table 76. AstraZeneca Revenue in H2 Antagonists or H2 blockers Business (2018-2024) & (US$ Million)
Table 77. AstraZeneca Recent Developments
Table 78. Bayer Company Details
Table 79. Bayer Business Overview
Table 80. Bayer H2 Antagonists or H2 blockers Product
Table 81. Bayer Revenue in H2 Antagonists or H2 blockers Business (2018-2024) & (US$ Million)
Table 82. Bayer Recent Developments
Table 83. Sun Pharma Company Details
Table 84. Sun Pharma Business Overview
Table 85. Sun Pharma H2 Antagonists or H2 blockers Product
Table 86. Sun Pharma Revenue in H2 Antagonists or H2 blockers Business (2018-2024) & (US$ Million)
Table 87. Sun Pharma Recent Developments
Table 88. Teva Company Details
Table 89. Teva Business Overview
Table 90. Teva H2 Antagonists or H2 blockers Product
Table 91. Teva Revenue in H2 Antagonists or H2 blockers Business (2018-2024) & (US$ Million)
Table 92. Teva Recent Developments
Table 93. Eisai Co. Company Details
Table 94. Eisai Co. Business Overview
Table 95. Eisai Co. H2 Antagonists or H2 blockers Product
Table 96. Eisai Co. Revenue in H2 Antagonists or H2 blockers Business (2018-2024) & (US$ Million)
Table 97. Eisai Co. Recent Developments
Table 98. Viatris Company Details
Table 99. Viatris Business Overview
Table 100. Viatris H2 Antagonists or H2 blockers Product
Table 101. Viatris Revenue in H2 Antagonists or H2 blockers Business (2018-2024) & (US$ Million)
Table 102. Viatris Recent Developments
Table 103. AOSAIKANG Pharma Company Details
Table 104. AOSAIKANG Pharma Business Overview
Table 105. AOSAIKANG Pharma H2 Antagonists or H2 blockers Product
Table 106. AOSAIKANG Pharma Revenue in H2 Antagonists or H2 blockers Business (2018-2024) & (US$ Million)
Table 107. AOSAIKANG Pharma Recent Developments
Table 108. Luoxin Pharma Company Details
Table 109. Luoxin Pharma Business Overview
Table 110. Luoxin Pharma H2 Antagonists or H2 blockers Product
Table 111. Luoxin Pharma Revenue in H2 Antagonists or H2 blockers Business (2018-2024) & (US$ Million)
Table 112. Luoxin Pharma Recent Developments
Table 113. LIVZON Company Details
Table 114. LIVZON Business Overview
Table 115. LIVZON H2 Antagonists or H2 blockers Product
Table 116. LIVZON Revenue in H2 Antagonists or H2 blockers Business (2018-2024) & (US$ Million)
Table 117. LIVZON Recent Developments
Table 118. Eastchina Pharma Company Details
Table 119. Eastchina Pharma Business Overview
Table 120. Eastchina Pharma H2 Antagonists or H2 blockers Product
Table 121. Eastchina Pharma Revenue in H2 Antagonists or H2 blockers Business (2018-2024) & (US$ Million)
Table 122. Eastchina Pharma Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global H2 Antagonists or H2 blockers Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global H2 Antagonists or H2 blockers Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Global H2 Antagonists or H2 blockers Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global H2 Antagonists or H2 blockers Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Drugs Store Case Studies
Figure 9. H2 Antagonists or H2 blockers Report Years Considered
Figure 10. Global H2 Antagonists or H2 blockers Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global H2 Antagonists or H2 blockers Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global H2 Antagonists or H2 blockers Market Share by Region: 2022 VS 2029
Figure 13. Global H2 Antagonists or H2 blockers Market Share by Players in 2022
Figure 14. Global Top H2 Antagonists or H2 blockers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in H2 Antagonists or H2 blockers as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by H2 Antagonists or H2 blockers Revenue in 2022
Figure 16. North America H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America H2 Antagonists or H2 blockers Market Share by Type (2018-2029)
Figure 18. North America H2 Antagonists or H2 blockers Market Share by Application (2018-2029)
Figure 19. North America H2 Antagonists or H2 blockers Market Share by Country (2018-2029)
Figure 20. United States H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe H2 Antagonists or H2 blockers Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe H2 Antagonists or H2 blockers Market Share by Type (2018-2029)
Figure 24. Europe H2 Antagonists or H2 blockers Market Share by Application (2018-2029)
Figure 25. Europe H2 Antagonists or H2 blockers Market Share by Country (2018-2029)
Figure 26. Germany H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China H2 Antagonists or H2 blockers Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China H2 Antagonists or H2 blockers Market Share by Type (2018-2029)
Figure 34. China H2 Antagonists or H2 blockers Market Share by Application (2018-2029)
Figure 35. Asia H2 Antagonists or H2 blockers Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia H2 Antagonists or H2 blockers Market Share by Type (2018-2029)
Figure 37. Asia H2 Antagonists or H2 blockers Market Share by Application (2018-2029)
Figure 38. Asia H2 Antagonists or H2 blockers Market Share by Region (2018-2029)
Figure 39. Japan H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America H2 Antagonists or H2 blockers Market Share by Country (2018-2029)
Figure 49. Brazil H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries H2 Antagonists or H2 blockers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Takeda Revenue Growth Rate in H2 Antagonists or H2 blockers Business (2018-2024)
Figure 56. Pfizer Revenue Growth Rate in H2 Antagonists or H2 blockers Business (2018-2024)
Figure 57. AstraZeneca Revenue Growth Rate in H2 Antagonists or H2 blockers Business (2018-2024)
Figure 58. Bayer Revenue Growth Rate in H2 Antagonists or H2 blockers Business (2018-2024)
Figure 59. Sun Pharma Revenue Growth Rate in H2 Antagonists or H2 blockers Business (2018-2024)
Figure 60. Teva Revenue Growth Rate in H2 Antagonists or H2 blockers Business (2018-2024)
Figure 61. Eisai Co. Revenue Growth Rate in H2 Antagonists or H2 blockers Business (2018-2024)
Figure 62. Viatris Revenue Growth Rate in H2 Antagonists or H2 blockers Business (2018-2024)
Figure 63. AOSAIKANG Pharma Revenue Growth Rate in H2 Antagonists or H2 blockers Business (2018-2024)
Figure 64. Luoxin Pharma Revenue Growth Rate in H2 Antagonists or H2 blockers Business (2018-2024)
Figure 65. LIVZON Revenue Growth Rate in H2 Antagonists or H2 blockers Business (2018-2024)
Figure 66. Eastchina Pharma Revenue Growth Rate in H2 Antagonists or H2 blockers Business (2018-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed